email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
736 - 750
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Rona Therapeutics In-licenses Exclusive Global Rights to Sanofi’s siRNA Platform
$5.00
Available
WuXi Biologics and WuXi AppTec to Spend $2.8 Billion to Build Separate Singapore Facilities
$5.00
Available
Luzhu Biotech Files for HK IPO to Support Shingles Vaccine and Adalimumab Biosimilar
$5.00
Available
NeuroFront Acquires Non-Opioid Neuropathic Pain Killer for $130 Million
$5.00
Available
ImmVira Says IV Administration of Oncolytic Herpes Simplex Virus Shows Promise
$5.00
Available
Frontera Closes $160 Million B Round for US-China Gene Therapy Development
$5.00
Available
Ascentage-Innovent NDA Accepted for Priority Review as Chronic Myeloid Leukemia Therapy
$5.00
Available
Innovent Says Type 2 Diabetes Therapy Meets Glycemic/Weight Loss Endpoints
$5.00
Available
Antengene to Test its Bispecific with Celularity’s Stem Cell Natural Killer Cell Therapy
$5.00
Available
Merck’s Uptune Program to Back Asia Health/Technology Startups with €100,000
$5.00
Available
Simcere Approved to Launch Myelosuppression-Prevention Drug in China
$5.00
Available
Suzhou CStone Pharma Engages Goldman Sachs to Explore Sale of Company
$5.00
Available
CStone Approved to Launch RET Inhibitor in Hong Kong for NSCLC
$5.00
Available
Epic Bio Completes $55 Million Funding Led by HK’s Horizon to Modify Gene Expression
$5.00
Available
Triastek and Lilly Collaborate on Using 3D Printing for Programed Release of GI Drugs
$5.00
Available